Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Caicun Zhou, Wenxiu Yao et al.|Journal of Thoracic Oncology|2021Cited by 311
Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG.Bo Shen, Hengjun Gao, Yufen Zheng et al.|PubMed|2020Cited by 90
A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trialYuxiang Ma, Hongyun Zhao, Yunpeng Yang et al.|Nature Medicine|2025Cited by 76
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutationsWenxian Wang, Fan Xia, Bin Lian et al.|The Innovation|2024Cited by 12
Mefatinib as first-line treatment of patients with advanced non–small cell lung cancer harboring rare EGFR mutations.Pingli Wang, Kai Wang, Liming Cao et al.|Journal of Clinical Oncology|2022Cited by 0